| Primary |
| Breast Cancer Metastatic |
28.2% |
| Premedication |
25.0% |
| Breast Cancer |
22.4% |
| Endometrial Cancer |
5.0% |
| Prophylaxis |
2.7% |
| Uterine Cancer |
2.4% |
| Pain |
1.9% |
| Prostate Cancer |
1.6% |
| Inflammatory Carcinoma Of The Breast |
1.3% |
| Non-small Cell Lung Cancer |
1.1% |
| Nausea |
1.0% |
| Bone Pain |
1.0% |
| Hypertension |
1.0% |
| Metastases To Central Nervous System |
1.0% |
| Pain In Extremity |
0.9% |
| Acne |
0.8% |
| Anaemia |
0.8% |
| Dermatitis |
0.8% |
| Breast Cancer Stage Iv |
0.6% |
| Anxiety |
0.5% |
|
| Vomiting |
11.7% |
| Death |
11.5% |
| Neuropathy Peripheral |
9.8% |
| No Adverse Event |
6.0% |
| Fatigue |
5.7% |
| Hypersensitivity |
5.2% |
| Malignant Neoplasm Progression |
5.2% |
| Circumstance Or Information Capable Of Leading To Medication Error |
4.9% |
| Rash |
4.9% |
| Neutropenia |
4.4% |
| Extravasation |
3.8% |
| Pain In Extremity |
3.6% |
| Stomatitis |
3.6% |
| Pleural Effusion |
3.3% |
| Drug Administration Error |
3.0% |
| Dyspnoea |
2.7% |
| Myalgia |
2.7% |
| Nausea |
2.7% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.7% |
| Medication Error |
2.5% |
|
| Secondary |
| Breast Cancer |
24.6% |
| Prostate Cancer |
19.5% |
| Breast Cancer Metastatic |
12.3% |
| Drug Use For Unknown Indication |
7.7% |
| Metastases To Central Nervous System |
5.6% |
| Inflammatory Carcinoma Of The Breast |
5.1% |
| Autoimmune Thyroiditis |
3.6% |
| Disease Progression |
3.1% |
| Pain |
3.1% |
| Neoplasm |
2.6% |
| Premedication |
2.1% |
| Endometrial Cancer |
1.5% |
| Metastases To Bone |
1.5% |
| Ovarian Cancer |
1.5% |
| Anxiety |
1.0% |
| Chemotherapy |
1.0% |
| Hypertension |
1.0% |
| Malignant Pleural Effusion |
1.0% |
| Neuropathy Peripheral |
1.0% |
| Systemic Lupus Erythematosus |
1.0% |
|
| Lymphopenia |
21.3% |
| Neuropathy Peripheral |
8.5% |
| Pleural Effusion |
8.5% |
| Neutropenia |
6.4% |
| Vomiting |
6.4% |
| White Blood Cell Count Decreased |
6.4% |
| Atrial Fibrillation |
4.3% |
| Cardiac Arrest |
4.3% |
| Drug Ineffective |
4.3% |
| Nausea |
4.3% |
| Sepsis |
4.3% |
| Thrombocytopenia |
4.3% |
| Adverse Event |
2.1% |
| Arthralgia |
2.1% |
| Bacteraemia |
2.1% |
| Cardio-respiratory Arrest |
2.1% |
| Deafness Bilateral |
2.1% |
| Dehydration |
2.1% |
| Disease Progression |
2.1% |
| Duodenal Ulcer |
2.1% |
|
| Concomitant |
| Breast Cancer |
24.4% |
| Metastases To Lung |
14.0% |
| Breast Cancer Metastatic |
12.8% |
| Metastases To Bone |
9.3% |
| Metastases To Liver |
9.3% |
| Drug Use For Unknown Indication |
4.7% |
| Arthralgia |
3.5% |
| Chemotherapy |
3.5% |
| Infection Prophylaxis |
3.5% |
| Pain In Extremity |
3.5% |
| Blood Pressure |
2.3% |
| Neoplasm Malignant |
2.3% |
| Bone Cancer Metastatic |
1.2% |
| Convulsion Prophylaxis |
1.2% |
| Depression |
1.2% |
| Idiopathic Thrombocytopenic Purpura |
1.2% |
| Nausea |
1.2% |
| Pain |
1.2% |
|
| Hepatomegaly |
10.0% |
| Pyrexia |
10.0% |
| Death |
6.7% |
| Ejection Fraction Decreased |
6.7% |
| Hypotension |
6.7% |
| Pain |
6.7% |
| Stomatitis |
6.7% |
| Vomiting |
6.7% |
| Alopecia |
3.3% |
| Completed Suicide |
3.3% |
| Diarrhoea |
3.3% |
| Drug Ineffective |
3.3% |
| Hypermetabolism |
3.3% |
| Injection Site Haematoma |
3.3% |
| Maculopathy |
3.3% |
| Metastases To Peritoneum |
3.3% |
| Osteonecrosis Of Jaw |
3.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.3% |
| Rash |
3.3% |
| Respiratory Disorder |
3.3% |
|
